Investigation of the vancomycin trough concentration in elderly patients with severe infection

CHEN Shumin; TIAN Wenyuan; BIAN Meng; ZHANG Jie

doi:10.3969/j.issn.1006-0111.2014.03.014

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To investigate the vancomycin trough concentration in elderly patients with severe infection and provide references for clinical use of drugs effectively. Methods According to the Ccr of elderly patients(56 cases), who were≥65 years old, the patients were divided into two groups, one with Ccr≥50 ml/min, which named group A, the other with Ccr between 20 ml/min and 50 ml/min, which named group B. The use of vancomycin, vancomycin steady-state plasma trough concentration and the differences of renal function were analyzed before and after in both two groups. Results There were 31cases of patients in group A(25 cases of them use vancomycin 1 g,q 12 h;other 6 cases use 0.5 g,q 12 h), 25 cases of patients in group B(15 cases of them use vancomycin 1 g,q 12 h;other 10 cases use 0.5 g,q 12 h). The percentage that the trough concentration of the patients who use two different scheme of using drugs in group A was between 10 mg/L and 20 mg/L is 12%(3/25) and 66.67%(4/6).The percentage that the trough concentration of the patients who used two different scheme of using drugs in group B was between 10 mg/L and 20 mg/L is 20%(3/15) and 60%(6/10). The percentage that trough concentrationis more than 20 mg/L is 73.33 %(11/15) and 30%(3/10). The serum creatinine value of the 15 patients of all cases except for group B of which vancomycin dosage was 1 g, q 12 h had significantly risen after using the drug(P<0.05). The urea nitrogen had no obvious change (P>0.05). The serum creatinine value and urea nitrogen of other patients had no significant change after using the drug (P>0.05). Group B had kidney toxicities observed in 5 patients, the dosage of vancomycin was 1 g, q 12 h, valley concentration>30 mg/L. There was no kidney toxicities observed in group A. Conclusion The use of vancomycin in elderly patients must depend on their Ccr. If the Ccr was larger than 50 ml/min, the use of vancomycin should be 1 g,q 12 h, and the Ccr was between 20 ml/min and 50 ml/min, the use should be 0.5 g. In addition, blood trough concentration need to be paid more attention in elderly patients in order to regulate the regimens according to the individual differences.

Investigation of the vancomycin trough concentration in elderly patients with severe infection

Fuxing Hospital, Capital Medical University, Beijing, 100038 China

Received Date: 2013-04-08

Rev Recd Date: 2013-11-28

Key words:

Abstract: Objective To investigate the vancomycin trough concentration in elderly patients with severe infection and provide references for clinical use of drugs effectively. Methods According to the Ccr of elderly patients(56 cases), who were≥65 years old, the patients were divided into two groups, one with Ccr≥50 ml/min, which named group A, the other with Ccr between 20 ml/min and 50 ml/min, which named group B. The use of vancomycin, vancomycin steady-state plasma trough concentration and the differences of renal function were analyzed before and after in both two groups. Results There were 31cases of patients in group A(25 cases of them use vancomycin 1 g,q 12 h;other 6 cases use 0.5 g,q 12 h), 25 cases of patients in group B(15 cases of them use vancomycin 1 g,q 12 h;other 10 cases use 0.5 g,q 12 h). The percentage that the trough concentration of the patients who use two different scheme of using drugs in group A was between 10 mg/L and 20 mg/L is 12%(3/25) and 66.67%(4/6).The percentage that the trough concentration of the patients who used two different scheme of using drugs in group B was between 10 mg/L and 20 mg/L is 20%(3/15) and 60%(6/10). The percentage that trough concentrationis more than 20 mg/L is 73.33 %(11/15) and 30%(3/10). The serum creatinine value of the 15 patients of all cases except for group B of which vancomycin dosage was 1 g, q 12 h had significantly risen after using the drug(P<0.05). The urea nitrogen had no obvious change (P>0.05). The serum creatinine value and urea nitrogen of other patients had no significant change after using the drug (P>0.05). Group B had kidney toxicities observed in 5 patients, the dosage of vancomycin was 1 g, q 12 h, valley concentration>30 mg/L. There was no kidney toxicities observed in group A. Conclusion The use of vancomycin in elderly patients must depend on their Ccr. If the Ccr was larger than 50 ml/min, the use of vancomycin should be 1 g,q 12 h, and the Ccr was between 20 ml/min and 50 ml/min, the use should be 0.5 g. In addition, blood trough concentration need to be paid more attention in elderly patients in order to regulate the regimens according to the individual differences.

HTML

Reference (10)

[1]	黄仲义,肖永红,张菁,等.万古霉素临床应用中国专家共识(2011)[J].中国新药与临床杂志,2011,30(8):561-573.
[2]	Liu C,Bayer A,Cosgrove SE,et al.Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin resistant Staphylococcus aureus infections in adults and children[J].Clin Infect Dis,2011,52:e18-e55.
[3]	Rybak M.Lomaestro B,Rotschafer JC,et al.Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists[J].Am J Health Syst Pharm,2009,66:82-98.
[4]	中华医学会甲氧西林耐药金黄色葡萄球菌感染治疗策略专家组.中华医学会感染与抗微生物治疗策略高峰论坛:甲氧西林耐药金黄色葡萄球菌感染的治疗策略——专家共识[J].中国感染与化疗杂志,2011,11(6):401-416.
[5]	Gilbert DN,Moellering RC,Eliopoulos MG,et al.The Sanford Guide to Antimicrobial Therapy 2010[M].40th ed.Sperryville,VA:Antimicrobial Therapy Inc,2010:25-27.
[6]	Park KH,Kim ES,Kim HS,et al.Comparison of the clinical features,bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S.aureus[J].J Antimicrob Chemother,2012,67:1843-1849.
[7]	Kullar R,Davis SL,Taylor TN,et al.Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort[J].Pharmacotherapy,2012,32:195-201.
[8]	Sakoulas G,Gold HS,Cohen RA,et al.Effect of prolonged vancomycin administration on methillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia[J].J Antimicrob Chemother,2006,57:699-704.
[9]	Thomson AH,Staatz CE,Tobin CM,et al.Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations[J].J Antimicrob Chemother 2009,63(5):1050-1057.
[10]	Yoshida M, Yasuda N, Nishikata M,et al. New recommendations for vancomycin dosage for patients with MRSA pneumonia with various degrees of renal function impairment[J].J Infect Chemother, 2005, 11(4): 182-188.

Message Board

Investigation of the vancomycin trough concentration in elderly patients with severe infection

doi: 10.3969/j.issn.1006-0111.2014.03.014

Abstract

References

Proportional views

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Related

Proportional views